CN111840428A - 一种抗炎杀菌舒缓祛痘的外用喷雾 - Google Patents

一种抗炎杀菌舒缓祛痘的外用喷雾 Download PDF

Info

Publication number
CN111840428A
CN111840428A CN202010718772.4A CN202010718772A CN111840428A CN 111840428 A CN111840428 A CN 111840428A CN 202010718772 A CN202010718772 A CN 202010718772A CN 111840428 A CN111840428 A CN 111840428A
Authority
CN
China
Prior art keywords
parts
acne
soothing
bactericidal
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010718772.4A
Other languages
English (en)
Inventor
邹婧
范士亮
刘凤彩
齐欢
梅彦昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tingbusu New Material Research Institute Co Ltd
Original Assignee
Nanjing Tingbusu New Material Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tingbusu New Material Research Institute Co Ltd filed Critical Nanjing Tingbusu New Material Research Institute Co Ltd
Priority to CN202010718772.4A priority Critical patent/CN111840428A/zh
Publication of CN111840428A publication Critical patent/CN111840428A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

本发明公开了一种抗炎杀菌舒缓祛痘的外用喷雾，其重量组分如下：马齿苋5～10份；丹参1～10份；苦参1～10份；金黄色洋甘菊1～10份；北美金缕梅5～10份；山茶5～10份；连翘5～10份；积雪草5～10份；芦荟5～10份；红没药醇5～15份；烟酰胺5～20份；神经酰胺5～20份；尿囊素5～10份；甘草酸二钾4～10份；矿物质水余量。本发明主要疗效为杀菌消毒，舒缓，祛痘，不添加防腐剂，采用多元醇体系进行防腐，对皮肤刺激小；从药理角度出发，增强皮肤的免疫力，提高皮肤的应激反应；能够调控皮肤水油平衡，促进血液循环，刺激皮肤再生，利用天然植物化合物的药理作用从多个皮肤病理学角度出发，干预、遏制痤疮的发生。

Description

一种抗炎杀菌舒缓祛痘的外用喷雾
技术领域
本发明涉及皮肤护理技术领域，具体为一种抗炎杀菌舒缓祛痘的外用喷雾。
背景技术
痤疮是一种最常见的影响青少年和年轻成人的皮肤疾病，它是一种发生于毛囊皮脂腺的慢性皮肤病，多发于头面部，颈部，前胸后背等皮脂腺丰富的部位，表现为粉刺、丘疹、结节、囊肿等损害，据文献报道，青少年中寻常痤疮的患病率为35%-90%，甚至更高，痤疮在20-29岁期间有消退趋势，但也可能持续至成年期或在成年期开始出现，青春期后痤疮主要累及女性，而青春期痤疮则以男性患者为主。
其实痤疮是受多种发病因素影响，其发病机理目前还不十分明了，但是目前可以肯定的是，它的发病原因主要是涉及四个主要因素，即毛囊角化过度，皮脂分泌增多，毛囊内痤疮丙烯杆菌滋生，皮肤炎症，这四种因素的复杂相互作用，刺激了固有免疫和细胞免疫反应，另外还受遗传影响，以及一定程度上可能会受饮食影响。
目前用于痤疮的治疗方法主要是内服外用疗法，服用抗生素类、抗雄性激素、皮质类固醇激素、维甲酸类、维生素类等药物，毒副作用极大，不适合常规使用；外用疗法，采用抗生素类药物、过氧化苯甲酰、维甲酸类等作为洗剂，以达到消炎、杀菌、去脂、清除皮面过多的油腻，去除毛孔堵塞物使皮脂外流通畅，但是毒副作用极大，不适合常规使用。
发明内容
本发明的目的在于提供一种抗炎杀菌舒缓祛痘的外用喷雾，以解决上述背景技术提出的问题。
为实现上述目的，本发明提供如下技术方案：一种抗炎杀菌舒缓祛痘的外用喷雾，其重量组分如下：马齿苋5～10份；丹参1～10份；苦参1～10份；金黄色洋甘菊1～10份；北美金缕梅5～10份；山茶5～10份；连翘5～10份；积雪草5～10份；芦荟5～10份；红没药醇5～15份；烟酰胺5～20份；神经酰胺5～20份；尿囊素5～10份；甘草酸二钾4～10份；矿物质水余量；
所述的抗炎杀菌舒缓的喷雾，该喷雾的组成及含量为：按重量份数计，马齿苋5～10份；丹参1～10份；金黄色洋甘菊1～10份；积雪草5～10份；红没药醇5～15份；烟酰胺5～20份；尿囊素5～10份；甘草酸二甲4～10份；矿物质水余量。
优选的，所述矿物质水82.8份，马齿苋提取液5份；丹参提取液2份；金黄色洋甘菊提取液1份；烟酰胺3份；尿囊素2份；甘草酸二甲2份；1，2-戊二醇2份，薰衣草纯露0.2份。
优选的，所述称取33份矿物质水，与液体组分：马齿苋提取液5份，丹参提取液2份，金黄色洋甘菊提取液1份，1，2-戊二醇2份，薰衣草纯露0.2份进行充分混合，制成A相，然后剩余50份矿物质水中加入，粉末组分：烟酰胺3份；尿囊素2份；甘草酸二甲2份，充分溶解混合均匀，制成B相，最后将A，B相进行混合，即得抗炎杀菌舒缓喷雾。
与现有技术相比，本发明的有益效果如下：
1、本发明主要疗效为杀菌消毒，舒缓，祛痘，不添加防腐剂，采用多元醇体系进行防腐，对皮肤刺激小；从药理角度出发，增强皮肤的免疫力，提高皮肤的应激反应；能够调控皮肤水油平衡，促进血液循环，刺激皮肤再生。
2、本发明的目的在于提供一种安全有效，温和不刺激的抗炎杀菌舒缓祛痘的外用喷雾，利用天然植物化合物的药理作用从多个皮肤病理学角度出发，干预、遏制痤疮的发生，科学配伍，充分利用配方中各种有效成分之间的协同性、有效性和兼容性，能将有效成分快速地渗透进皮肤，本发明的抗炎杀菌舒缓祛痘的外用喷雾，温和无刺激，可以随时用于身体或面部，兼具修护和滋养作用。
具体实施方式
下面将结合本发明实施例中，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
为实现上述目的，本发明提供如下技术方案：一种抗炎杀菌舒缓祛痘的外用喷雾，其重量组分如下：马齿苋5～10份；丹参1～10份；苦参1～10份；金黄色洋甘菊1～10份；北美金缕梅5～10份；山茶5～10份；连翘5～10份；积雪草5～10份；芦荟5～10份；红没药醇5～15份；烟酰胺5～20份；神经酰胺5～20份；尿囊素5～10份；甘草酸二钾4～10份；矿物质水余量；
抗炎杀菌舒缓的喷雾，该喷雾的组成及含量为：按重量份数计，马齿苋5～10份；丹参1～10份；金黄色洋甘菊1～10份；积雪草5～10份；红没药醇5～15份；烟酰胺5～20份；尿囊素5～10份；甘草酸二甲4～10份；矿物质水余量。
实施例一：
本实施例中，抗炎杀菌舒缓的喷雾成分和含量如下：
矿物质水82.8份，马齿苋提取液5份；丹参提取液2份；金黄色洋甘菊提取液1份；烟酰胺3份；尿囊素2份；甘草酸二甲2份；1，2-戊二醇2份，薰衣草纯露0.2份。
本实施例的配方用于制作喷雾，制作方法如下：
称取33份矿物质水，与液体组分：马齿苋提取液5份，丹参提取液2份，金黄色洋甘菊提取液1份，1，2-戊二醇2份，薰衣草纯露0.2份进行充分混合，制成A相，然后剩余50份矿物质水中加入，粉末组分：烟酰胺3份；尿囊素2份；甘草酸二甲2份，充分溶解混合均匀，制成B相，最后将A，B相进行混合，即得抗炎杀菌舒缓喷雾。
实施例二：
本实施例中，抗炎杀菌舒缓的喷雾成分和含量如下：
矿物质水86.8份，马齿苋提取液4份；丹参提取液1份；连翘提取液1份；积雪草提取液1份；神经酰胺2份；尿囊素2份；1，2-戊二醇2份，迷迭香纯露0.2份。
本实施例的配方用于制作喷雾，制作方法如下：
称取36.8份矿物质水，与液体组分：马齿苋提取液4份，丹参提取液1份，连翘提取液1份，积雪草提取液1份，1，2-戊二醇2份，迷迭香纯露0.2份进行充分混合，制成A相，然后剩余50份矿物质水中加入，粉末组分：神经酰胺3份，尿囊素2份充分溶解混合均匀，制成B相，最后将A，B相进行混合，即得抗炎杀菌舒缓喷雾。
实施例三：
本实施例中，抗炎杀菌舒缓的喷雾成分和含量如下：
矿物质水82.8份，马齿苋提取液5份；丹参提取液2份；连翘提取液1份；积雪草提取液1份；金黄色洋甘菊提取液1份；烟酰胺3份；尿囊素2份；1，2-戊二醇2份，迷迭香纯露0.2份。
本实施例的配方用于制作喷雾，制作方法如下：
称取32.8份矿物质水，与液体组分：马齿苋提取液4份，丹参提取液1份，连翘提取液1份，积雪草提取液1份，1，2-戊二醇2份，迷迭香纯露0.2份进行充分混合，制成A相，然后剩余50份矿物质水中加入，粉末组分：神经酰胺3份，尿囊素2份充分溶解混合均匀，制成B相，最后将A，B相进行混合，即得抗炎杀菌舒缓喷雾。
将上述的抗炎杀菌舒缓喷雾进行了人体试验，选择15-30岁面部有痤疮，粉刺，丘疹等相关皮问题的志愿者试用，调查结果显示治疗痤疮有效率达85%以上，产品安全无刺激，
尽管已经示出和描述了本发明的实施例，对于本领域的普通技术人员而言，可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型，本发明的范围由所附权利要求及其等同物限定。

Claims (3)

1.一种抗炎杀菌舒缓祛痘的外用喷雾，其特征在于：其重量组分如下：马齿苋5～10份；丹参1～10份；苦参1～10份；金黄色洋甘菊1～10份；北美金缕梅5～10份；山茶5～10份；连翘5～10份；积雪草5～10份；芦荟5～10份；红没药醇5～15份；烟酰胺5～20份；神经酰胺5～20份；尿囊素5～10份；甘草酸二钾4～10份；矿物质水余量；
所述的抗炎杀菌舒缓的喷雾，该喷雾的组成及含量为：按重量份数计，马齿苋5～10份；丹参1～10份；金黄色洋甘菊1～10份；积雪草5～10份；红没药醇5～15份；烟酰胺5～20份；尿囊素5～10份；甘草酸二甲4～10份；矿物质水余量。
2.根据权利要求1所述的一种抗炎杀菌舒缓祛痘的外用喷雾，其特征在于：所述矿物质水82.8份，马齿苋提取液5份；丹参提取液2份；金黄色洋甘菊提取液1份；烟酰胺3份；尿囊素2份；甘草酸二甲2份；1，2-戊二醇2份，薰衣草纯露0.2份。
3.根据权利要求1所述的一种抗炎杀菌舒缓祛痘的外用喷雾，其特征在于：所述称取33份矿物质水，与液体组分：马齿苋提取液5份，丹参提取液2份，金黄色洋甘菊提取液1份，1，2-戊二醇2份，薰衣草纯露0.2份进行充分混合，制成A相，然后剩余50份矿物质水中加入，粉末组分：烟酰胺3份；尿囊素2份；甘草酸二甲2份，充分溶解混合均匀，制成B相，最后将A，B相进行混合，即得抗炎杀菌舒缓喷雾。
CN202010718772.4A 2020-07-23 2020-07-23 一种抗炎杀菌舒缓祛痘的外用喷雾 Pending CN111840428A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010718772.4A CN111840428A (zh) 2020-07-23 2020-07-23 一种抗炎杀菌舒缓祛痘的外用喷雾

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010718772.4A CN111840428A (zh) 2020-07-23 2020-07-23 一种抗炎杀菌舒缓祛痘的外用喷雾

Publications (1)

Publication Number Publication Date
CN111840428A true CN111840428A (zh) 2020-10-30

Family

ID=72950783

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010718772.4A Pending CN111840428A (zh) 2020-07-23 2020-07-23 一种抗炎杀菌舒缓祛痘的外用喷雾

Country Status (1)

Country Link
CN (1) CN111840428A (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104922056A (zh) * 2015-05-29 2015-09-23 台山美环健芦荟制品有限公司 一种芦荟鲜汁凝胶及其制备方法和应用
CN107260636A (zh) * 2017-07-20 2017-10-20 山东彩娜菲诗生物科技有限公司 一种护肤液及其制备方法
CN110368348A (zh) * 2019-08-29 2019-10-25 广州重生化妆品实业有限公司 一种祛痘原液的配方及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104922056A (zh) * 2015-05-29 2015-09-23 台山美环健芦荟制品有限公司 一种芦荟鲜汁凝胶及其制备方法和应用
CN107260636A (zh) * 2017-07-20 2017-10-20 山东彩娜菲诗生物科技有限公司 一种护肤液及其制备方法
CN110368348A (zh) * 2019-08-29 2019-10-25 广州重生化妆品实业有限公司 一种祛痘原液的配方及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
谢艳君等: "化妆品中常用中草药原料研究进展", 《中国中药杂志》 *

Similar Documents

Publication Publication Date Title
US7282224B1 (en) Pain relief composition
IL260028B2 (en) Baby care products
US20060083708A1 (en) Composition using mineral salts for cosmetic or therapeutic treatment
US20130052271A1 (en) Compositions and Methods for Treating Pain
CN106074206B (zh) 一种护肤主剂、制备方法及其应用
CN110035797B (zh) 用于治疗痤疮的具有益生元特性的协同草药组合物
WO2016197015A1 (en) Personal care products: kit and methods of use and making
CN111801108A (zh) 局部皮肤护理组合物
CA3148643A1 (en) Topical formulations comprising cannabidiol, method of preparing the composition and use thereof
KR20110074513A (ko) 피부 감염의 국소 치료법
EP1074245A2 (en) Composition using mineral salts for therapeutic treatment
TW201417822A (zh) 用於治療痤瘡的局部用組成物
CN112472653A (zh) 一种祛痘芦荟胶及其制备方法
CN109620879A (zh) 一种清湿修复膏及其制备方法
CN102233006A (zh) 一种用于治疗痤疮的复方中药提取物及其应用
CN111840428A (zh) 一种抗炎杀菌舒缓祛痘的外用喷雾
ITUB20159582A1 (it) Composizione, per uso topico, utile per la prevenzione di disturbi di tipo infiammatorio e/o infettivo delle mucose.
CN114129649A (zh) 一种可促进皮肤屏障修复护理用的冷敷凝胶
EP2588095B1 (en) Composition for the treatment of acne vulgaris
CN113749986A (zh) 一种乳木果油敏感肌肤全效修护乳液及其制备方法和应用
KR20110049201A (ko) 여드름 피부 병변 현상 개선용 세안화장료 조성물 및 그 추출방법
KR102420354B1 (ko) 순환 활성 로션 조성물 및 그 제조방법
JP6853406B1 (ja) 抗毛嚢炎用外用組成物
CN113995701B (zh) 一种祛痘和消除痘印的组合物及其制备方法和应用
Curt-Mola et al. Comparative Effectiveness of Alternative Medication in Minor Aphtous Stomatitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201030